BP-1-102 is an orally active, effective, and specific STAT3 inhibitor that binds Stat3 (Kd: 504 nM), blocks Stat3-phosphotyrosine (pTyr) peptide interactions and Stat3 activation (4-6.8 µM), and selectively inhibits the migration, survival, growth, and invasion of Stat3-dependent tumor cells. The BP-1-102-mediated inhibition of aberrantly active Stat3 in tumor cells suppresses the expression of [c-Myc, Bcl-xL, Cyclin D1, Survivin, and VEGF].
Molecular Weight:
626.59
Purity:
99.81%
CAS Number:
[1334493-07-0]
Formula:
C29H27F5N2O6S
Target:
STAT
T3708
* VAT and and shipping costs not included. Errors and price changes excepted
